Actively Recruiting
Pilot Study to Screen for Early Multiple Myeloma in High-Risk Adults 30 and Older in Charlotte Area Residents
Led by Wake Forest University Health Sciences · Updated on 2026-07-13
1665
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying multiple myeloma, a type of plasma cell disorder, by identifying it early during the precancerous MGUS stage. The goal is to reduce delayed diagnosis risks, lower disease-related complications at progression, and improve long-term outcomes for high-risk adults aged 30 and older living in Charlotte and nearby areas. This pilot study aims to test the feasibility of screening methods before launching a larger trial. Participants aged 30 or above will be screened for monoclonal gammopathy through a blood sample over a one-year period. Those who test positive will be referred for further diagnosis to confirm MGUS, smoldering multiple myeloma, or other related plasma cell disorders. Individuals diagnosed with MGUS or smoldering multiple myeloma can join a longitudinal study and will be followed for up to 10 years. Participants with other plasma cell disorders will have their baseline data recorded and be monitored for overall survival. During the study, participants will undergo blood draws for laboratory tests and may complete informed consent including HIPAA authorization. Researchers will measure enrollment numbers, screening results, diagnoses, disease progression, and community engagement. Follow-up includes monitoring disease signs and psychological counseling referrals. Total study involvement may last up to 10 years or until study completion in 2035, with ongoing data collection and evaluations to improve early detection and outcomes.
CONDITIONS
Brief Title
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
Research Team
M
Margarita Dzhanumova
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here